Retension Pharmaceuticals, Inc.
RTSN
10 insider filings · Latest: Oct 13, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 13, 2026 | Oct 13 10:12 PM | Eric L. KellerDirector, CHIEF EXECUTIVE OFFICER | Purchase | 20,800 | $12.00 | $249.6K | 423,377(D) | View → |
| Oct 13, 2026 | Oct 13 10:10 PM | Franklin M BergerDirector | Purchase | 10,000 | $12.00 | $120.0K | 10,000(I) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Oct 13, 2026 | Oct 13 10:12 PM | Eric L. KellerDirector, CHIEF EXECUTIVE OFFICER | Conversion | 41,030 | — | 0(D) | View → |
| Oct 13, 2026 | Oct 13 10:12 PM | Eric L. KellerDirector, CHIEF EXECUTIVE OFFICER | Grant/Award | 255,174 | $11.63 | 255,174(D) | View → |
| Oct 13, 2026 | Oct 13 10:12 PM | Paul SweetnamCHIEF SCIENTIFIC OFFICER | Conversion | 6,666 | — | 0(I) | View → |
| Oct 13, 2026 | Oct 13 10:11 PM | Donald OldsDirector | Conversion | 5,637 | — | 0(D) | View → |
| Oct 13, 2026 | Oct 13 10:11 PM | Pavan CheruvuDirector | Grant/Award | 5,636 | $11.63 | 5,636(D) | View → |
| Oct 13, 2026 | Oct 13 10:11 PM | Sabine BissonCHIEF OPERATING OFFICER | Conversion | 4,115 | — | 0(D) | View → |
| Oct 13, 2026 | Oct 13 10:10 PM | Franklin M BergerDirector | Conversion | 12,517 | — | 0(D) | View → |
| Oct 13, 2026 | Oct 13 10:10 PM | Michael J BerendtDirector | Conversion | 6,666 | — | 0(D) | View → |
| Oct 8, 2026 | Oct 9 1:39 AM | Michael J BerendtDirector | Grant/Award | 5,636 | $12.00 | 5,636(D) | View → |
| Oct 8, 2026 | Oct 9 1:39 AM | Donald OldsDirector | Grant/Award | 5,636 | $12.00 | 5,636(D) | View → |
| Oct 8, 2026 | Oct 9 1:38 AM | Franklin M BergerDirector | Grant/Award | 5,636 | $12.00 | 5,636(D) | View → |